FDA Drug Application (205266) for ODOMZO by NOVARTIS PHARMS CORP

Back to FDA Applications sponsored by NOVARTIS PHARMS CORP

Application Number205266
Product Number001
FormCAPSULE;ORAL
DosageEQ 200MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameODOMZO
Active IngredientSONIDEGIB PHOSPHATE



Back to FDA Applications sponsored by NOVARTIS PHARMS CORP